Adjunct Staff

Photo Yaseen ArabiAssociate Professor Yaseen Arabi MD FCCM FCCP
Adjunct Associate Professor

Dr Yaseen Arabi's current appointments include Chair and Consultant in the Intensive Care Department, and Medical Director of Respiratory Services, King Abdulaziz Medical City; and Associate Professor, King Saud Bin Abdulaziz University, Riyadh, Kingdom of Saudi Arabia. He is also the current Fellow of the American College of Critical Care Medicine (FCCM) and the American College of Chest Physicians (FCCP). His qualifications include an MD from Damascus University School of Medicine, Syria. After completing his MD, Dr Arabi undertook a postdoctoral period from 1992 to 1994 at Wayne State University School of Medicine in Detroit, Michigan, USA. He was appointed as a chief medical resident from 1994-1995. Then he completed Pulmonary and Critical Care Fellowship at the University of Wisconsin in 1998. In 1998 Dr Arabi moved to Riyadh, in the Kingdom of Saudi Arabia to take up a position as a Consultant in the Intensive Care Department of the King Abdulaziz Medical City. In 2007 Dr Arabi became Chair of the Intensive Care Department. He has an international reputation for quality research in the field of critical care and has published extensively (>140 papers) including three publications in the prestigious New England Journal of Medicine. One of these was in collaboration with the ANZIC-RC (Cooper DJ, Rosenfeld JV, Murray L, Arabi YM, et al. Decompressive craniectomy in diffuse traumatic brain injury. N Engl J Med. 2011;364(16):1493-502). Dr Arabi received several prestigious awards including the Bary A. Shapiro Memorial Award for Excellence in Critical Care Management from the Society of Critical Care Medicine (SCCM), USA in 2011.
Photo of Cecile AubronDr Cécile Aubron MD PhD
Adjunct Senior Research Fellow, ANZIC-RC
Email

Dr Cécile Aubron is a French intensive care physician who was the ANZIC-RC's Senior Research Fellow (SRF); in 2010 and a SRF at the ANZIC-RC with the Blood-CRE from 2013 to 2014. In 2010 Cécile was actively involved in the ANZIC-RC's "Age of Blood" research project including the feasibility pilot study in preparation for the large randomised controlled trial (RCT) and the publishing of the pilot study. Dr Aubron is an Associate Investigator on the ANZIC-RC's successful $2.7m NHMRC grant, STandaRd Issue TrANsfusion versuS Fresher red blood cell Use in intenSive carE (TRANSFUSE) RCT. In 2011 she was the co-recipient of The Alfred ICU - Monash University Research Fellowship. Since 2015, Dr Aubron has worked as an Intensivist in the Service de Réanimation Médicale, Centre Hospitalier et Universitaire de Brest (Medical Intensive Care Unit, Teaching Hospital/University affiliated hospital) in Brest, France. Dr Aubron originally trained in Paris, France, and her qualifications include a Master's degree in Microbiology; an MD; and a PhD entitled "Study of the Escherichia coli metabolic polymorphism, involvement in adaptation and virulence". Dr Aubron has published 7 book chapters and 20 papers in international refereed journals on topics such as blood, infectious diseases, including pandemic (H1N1 (2009) influenza epidemic) research, and pharmacokinetic modeling research. She has delivered conference presentations in France, Senegal and Australia.

Publications in PubMed

Photo of Tracey BucknallProfessor Tracey Bucknall PhD
Adjunct Professor

Professor Tracey Bucknall is currently Professor and Associate Head of School (Research) in the School of Nursing and Midwifery at Deakin University, and Director of Nursing Research and Head of the Deakin-Alfred Health Nursing Research Centre, Alfred Health. For more than a decade, her practice specialty was critical care, where she held a variety of clinical, educational and research appointments in private and public hospitals. She is an Honorary Professorial Fellow at both Monash University and the Cabrini Institute, and has been a Visiting Professor at the University of Alberta, University of Bangor, University of Birmingham, University of Iowa, University of California, and University of Sheffield. Since 2005, Prof Bucknall has held joint clinical and academic appointments that have enabled her to conduct research that focuses improving clinical decision making and patient safety, alleviating patient symptoms and increasing the uptake of research evidence in practice. As a decision scientist Prof Bucknall has successfully obtained more than $10m in competitive research funding, presented her research nationally and internationally, and published over 100 scholarly publications in critical care, pain, nursing and knowledge translation. Prof Bucknall currently serves on the Australian Commission for Safety and Quality in Health Care (ACSQHC) Recognising and Responding to Clinical Deterioration Advisory Committee, NMHRC Grant Review Panels and ANZICs Clinical Trial's Group TRIP Subcommittee. She was a member of the ACSQHC Technical Advisory Panel, and the National Research Advisory Committee of the Australian College of Critical Care Nurses (ACCCN) for more than a decade. Her editorial roles have included ten years as an Associate Editor for Worldviews on Evidence Based Nursing, Associate Editor for PLoS One, and Editorial Board Member for Australian Critical Care. She is currently an Editorial Board Member for BMC Health Service Research and reviews for numerous international journals.
Photo of Gilles CapellierProfessor Gilles Capellier MD MSc PhD
Adjunct Professor

Professor Capellier is an Adjunct Professor with the ANZIC-RC. He was a Visitor at the ANZIC-RC for one year (2011-2012) when he was on sabbatical from the Université de Franche-Comté, Besançon, France where he runs a critical care and emergency department, is a member of the Board of the Medical Faculty, and a Professor of Intensive Care Medicine. His qualifications include an MD; certification as a Critical Care Physician from the Hôpital Claude Bernard, Paris; a Master of Science degree in Respiratory and Circulatory Physiology and Pathophysiology (Thesis title: Pulmonary neutrophils accumulation during peritonitis induced by cecal ligation and perforation); and a PhD (Thesis title: Pulmonary oxygen toxicity - demonstration of clinical and experimental tolerance). Professor Capellier's main research foci are Acute Respiratory Distress Syndrome (ARDS), oxygen toxicity tolerance, and ICU management of ARDS including extracorporeal membrane oxygenation (ECMO). He is also interested in ICU organisation and quality-safety in care. His experience includes a year as a Clinical Fellow and a Clinical Research Fellow at the Toronto General Hospital, Canada. Professor Capellier has published over 90 peer-reviewed papers and book chapters including in the prestigious journals JAMA and the American Journal of Respiratory and Critical Care Medicine. He has also been an invited speaker at numerous international and national conferences.
Photo of Marianne ChapmanAssociate Professor Marianne Chapman BMBS PhD DA(UK) FFARCSI FANZCA FCICM
Adjunct Associate Professor

Dr Chapman is a Senior Staff Specialist in Intensive Care Medicine at the Royal Adelaide Hospital and a Clinical Associate Professor in the School of Medicine at the University of Adelaide. Her primary degree was from Flinders University of South Australia, graduating in 1982. She trained as an anaesthetist in Plymouth in the UK and worked in Kenya for 12 months before returning to complete intensive care training in Adelaide in 1990. She then spent a further year working in the Hadassah Hospital in Jerusalem in 1993/94. She has a PhD from the University of Adelaide which involved the investigation of abnormalities in gastrointestinal motility underlying problems with the administration of nutrition to the critically ill. She has been the Director of Research in the ICU at the Royal Adelaide Hospital (RAH) since 1998 and is the Chair of the RAH ICU Research Committee. She is also a member of the Board of Examiners of the College of Intensive Care Medicine and is involved in a number of other committees including the Formal Project Assessment Panel - College of Intensive Care Medicine. Her clinical research interests include gastrointestinal dysfunction underlying problems with the administration of nutrition, and glucose metabolism in the critically ill. This work is the result of a very successful collaboration with the Departments of Medicine and Gastroenterology in the University of Adelaide, the Royal Adelaide Hospital and the Repatriation General Hospital, and forms part of a Centre of Clinical Research Excellence grant from the NHMRC awarded in 2012. She currently supervises PhD students undertaking clinical research in the ICU at the Royal Adelaide Hospital. She has published over 100 journal articles, received over $2 million in research funding, and has given invited presentations at national and international meetings.
Photo of Dr Anthony DelaneyDr Anthony Delaney MBBS MSc FACEM FCICM
Adjunct Senior Research Fellow

Dr Anthony Delaney is an Adjunct Senior Research Fellow with the ANZIC-RC. He is a Fellow of the Australasian College for Emergency Medicine (ACEM) and College of Intensive Care Medicine (CICM). Dr Delaney has a Master of Science degree in Clinical Epidemiology from the University of Calgary. He is a Staff Specialist in the Malcolm Fisher Intensive Care Unit at the Royal North Shore Hospital. Dr Delaney is on the Management Committee of the ANZIC-RC's ARISE study.
Photo of Andrew FlintAndrew Flint BEng(Hon) BEcon(Hon) RAN 
Adjunct Research Fellow, ANZIC-RC

Andrew Flint is a Medical Officer with the Royal Australian Navy. His diverse qualifications include a Bachelor of Engineering (Honours) (2008), and a Bachelor of Economics (2008) (Honours in 2009). He will complete his Bachelor of Medicine/Bachelor of Surgery in 2014. He is the recipient of numerous awards including the Chancellor's Award for Outstanding Academic Performance at ANU (2005, 2006 and 2007), the Undergraduate Aerospace Engineering Design Prize from the American Institute of Aeronautics and Astronautics (2008), the EVA Junior Business Fellow from EVA Finland, the First Wave Scholarship from the General Practice Students' Network (2012-3), and a scholarship from the National Rural Health Students' Network. Andrew is currently collaborating with the ANZIC-RC and the Centre of Research Excellence in Patient Blood Management on the effect of platelet transfusion age on outcome in critical illness and major trauma patients.

Photo of Peter KrugerAssociate Professor Peter Kruger MBBS BSc(Hons) FANZCA FCICM
Adjunct Senior Lecturer

Dr Kruger is the Deputy Director of Intensive Care at the Princess Alexandra Hospital in Brisbane and Associate Professor of Anaesthesia and Critical Care at the University of Queensland. He is a member of the Executive of the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS-CTG) and a current examiner in both the Anaesthesia and Intensive Care college primary examinations. He has an interest in clinical and laboratory research and is the chief investigator of the NHMRC funded, CTG endorsed STATInS trial, A phase II randomised controlled trial of atorvastatin therapy in intensive care patients with severe sepsis. His research interests include drug behaviour in critically ill patients, the role of statin therapy in patients with sepsis, antibiotic therapy in critical illness and body fluid dynamics.

Photo of Colin McArthurDr Colin McArthur BHB MBChB FANZCA FCICM
Adjunct Senior Research Fellow

Dr Colin McArthur is Clinical Director, Department of Critical Care Medicine, Auckland City Hospital; Medical Advisor - Quality & Safety, Auckland District Health Board; and Honorary Clinical Lecturer, Department of Surgery, University of Auckland. He is also the Chair of the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS-CTG) and its representative on the ANZIC-RC Advisory Board. He trained in medicine in Auckland and is a Fellow of the College of Intensive Care Medicine (FCICM) and a Fellow of the Australian and New Zealand College of Anaesthetists (FANZCA). He has been an investigator in 24 investigator-initiated studies (and also 16 commercial studies) and an author of 35 publications, mostly multi-centre clinical intensive care research. Since 2001, he has been on the management and/or writing committee of eight NHMRC or HRCNZ-funded studies, five of which have been completed and published in the New England Journal of Medicine and three are on-going. He is an investigator on several current ANZIC-RC studies including the ARISE, INFINITE, EPO-TBI and POLAR studies. He was also an investigator on the ANZIC-RC's now completed STATINS study. His interests include research methodology and ethics, traumatic brain injury, sepsis, nutrition, and severe influenza.

Dr Shay McGuinnessDr Shay McGuinness
Adjunct Senior Research Fellow

Dr Shay McGuinness is Director of Research at the Cardiothoracic and Vascular Intensive Care Unit (CVICU), Auckland City Hospital, New Zealand, and Clinical Director of the Air Ambulance Service, Auckland District Health Board. Dr McGuinness is the New Zealand representative on both the ANZIC-RC's Advisory Board and the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS-CTG) Executive, and is also the Chair of the ANZICS-CTG Capacity Working Group Sub-committee. Dr McGuinness trained at medicine and surgery in Sheffield, United Kingdom. He has published more than 25 journal papers including articles in New England Journal of Medicine (NEJM) and Journal of the American Medical Association (JAMA). He has been a Principal or Co-investigator on peer reviewed research grants exceeding (NZ)$2.9 million including 5 NZHRC grants. His research interests include randomised clinical trials in non-invasive ventilation and renal failure. Dr McGuinness is a member of the Management Committees of the ANZIC-RC's PHARLAP-RCT and Supplemental PN trials.

Photo of Cristina Morganti-KossmannAssociate Professor Cristina Morganti-Kossmann PhD
Adjunct Associate Professor

Dr Morganti-Kossmann is an Adjunct Associate Professor at the ANZIC-RC. In 1984 she obtained a doctoral degree in Biology from the University of Rome "la Sapienza", Department of Biochemistry and Istituto Superiore di Sanità (National Institute of Health) Rome, Italy. After completing her doctoral thesis, Dr Morganti-Kossmann undertook a postdoctoral period at the Cancer Institute Regina Elena in Rome. In 1987 she was awarded a fellowship by the Boehringer Ingelheim Fund, which allowed her to work at the prestigious Institute of Neurobiology lead by Prof M Schachner at the University of Heidelberg, Germany. In 1989 she worked for 2 years as a guest researcher at the Div. Cellular Immunology, NIDR, National Institutes of Health, Bethesda, USA. Upon her relocation to Switzerland, in 1991, Dr Morganti-Kossmann established her own neurotrauma research group at the University of Zurich, where she began working in neurotrauma research. There she developed comprehensive studies to characterise neuroinflammatory processes and biomarkers of brain injury in patients with severe traumatic brain injury. This novel bench-to-bed-side research allowed her to extend the clinical studies with experimental models of focal and diffuse TBI and glial cultures to deepen the functional role of cytokines and immune cells. In 1998 Dr Morganti-Kossmann was nominated Group Leader within the Institute of Neuroscience of Zurich established by Prof M Schwab.
In 2001, she moved to Melbourne to work at the Department of Trauma Surgery of the Alfred Hospital as a Senior Neuroscientist. Over the past 13 years, Dr Morganti-Kossmann has been instrumental in expanding neurotrauma research in Melbourne including successful large collaborative program grants funded by the Transport Accident Commission (Victorian Trauma Foundation and Victorian Neurotrauma Initiative). She had a pivotal role in the establishment of the National Trauma Research Institute at the Alfred Hospital in which she was Head of Basic Research from 2004 until 2012. In 2006, Dr Morganti-Kossmann was appointed Associate Professor at Monash University and Honorary Senior Research Fellow at the Centre for Neuroscience of Melbourne University. In 2008 she was awarded the only 3-year Senior Research Fellowship given in Victoria by the Victorian Neurotrauma Initiative. Over the past years she served as an executive member of various scientific advisory boards (Neurosciences Victoria, and AMREP, among others). She has been an advisor on basic brain trauma research during the establishment of the Victorian Neurotrauma Initiative. In 2012 she was appointed Research Associate Professor at the Department of Child Health, Phoenix Children's Hospital, University of Arizona, Phoenix, to join the Translational Neurotrauma Research Program at the Barrow Neurological Institute where she pays extended visits every year. Dr Morganti-Kossmann published 80 research articles, 16 reviews and 17 book chapters with a total of >4300 citations and H index=39 (Scopus since 1995). She has been an invited speaker in numerous international and national conferences including multiple lectures given at the biennial International Neurotrauma Symposia.
She contributes to the research activities of the ANZIC Research Centre with a sub-study of the Erythropoietin Randomised Clinical Trial in patients with moderate and severe traumatic brain injury to assess the validity of biomarkers of brain injury as early predictors of long-term outcome.

Photo of John MyburghProfessor John Myburgh MBBCh PhD FANZCA FCICM
Adjunct Professor

Professor Myburgh is an Enabling Grant Chief Investigator and a foundation member and past Chair of the ANZICS Clinical Trials Group (ANZICS-CTG). He is the Director of the Division of Critical Care and Trauma at The George Institute for Global Health and Professor of Critical Care at the University of New South Wales. He holds honorary professorial appointments at the Universities of Sydney and Monash. He is a senior physician in the Department of Intensive Care Medicine at St George Hospital, Sydney. He has been involved in laboratory and clinical research since 1989. He has received over $18M in NHMRC funding, $8M in international grants, $1M in institutional grants and $8M in unrestricted commercial grants to a total of $36M since 2000. He published over 100 original articles, including 4 papers in the New England Journal of Medicine, and 20 book chapters. His research interests include catecholamine pharmacodynamics, traumatic brain injury, fluid resuscitation and endocrine homeostasis in critical illness. He has delivered over 20 plenary lectures at international meetings. Current research activities include large-scale trials of fluid resuscitation (CHEST), steroids in septic shock, glycaemic control and thermoregulation in critical illness. He has established postgraduate research programs at the George Institute for PhD and MPH students through the Universities of New South Wales and Sydney. In addition to his research activities, he has a long-standing involvement in education and is the current President of the College of Intensive Care Medicine. Within the College, he established an independent Annual Scientific Meeting in 2005 and served as a fellowship examiner for 12 years.

Photo of Lynette NewbyMs Lynette Newby MHSc(Clin Data Mgt)
Adjunct Research Fellow

Ms Newby is the Senior Research Coordinator in the Department of Critical Care Medicine and the Clinical Nurse Specialist (Multiple Sclerosis) in the Department of Neurology, Auckland City Hospital, New Zealand. She is a Management Committee Member on the ANZIC-RC's Prophylactic Hypothermia Trial to Lessen Traumatic Brain Injury (POLAR) Randomised Controlled Trial and a Monitor for the Australasian Resuscitation In Sepsis Evaluation (ARISE) Randomised Control Trial for the study's New Zealand sites. Since 1997, she has been involved in clinical research in critical care at Auckland City Hospital. Prior to that Ms Newby gained more than a decade of experience in intensive care nursing in New Zealand, the USA, Zimbabwe, Saudi Arabia, the United Kingdom, Australia and Hong Kong. Ms Newby has been an author/investigator on a number of publications, mostly multi-centre clinical intensive care research, including publications in prestigious journals such as the New England Journal of Medicine. Ms Newby is a member of the Auckland Regional Management Committee of the New Zealand Nurses Organisation - Critical Care Nurses Section (NZNO-CCNS).

Photo of Rachael ParkeDr Rachael Parke MHSc PhD
Adjunct Senior Research Fellow

Dr Parke is the Nurse Senior Researh Fellow in the Cardiothoracic and Vascular Intensive Care Unit at Auckland City Hospital, New Zealand. She was awarded the degree of Doctor of Philosophy in 2014, and is currently leading a program of research investigating the effects of fluid management following cardiac surgery. She has published over 50 articles and been an investigator on peer reviewed research grants exceeding NZ$3 million. Rachael is the current Secretary of the ANZICS Clinical Trials Group Executive Committee and Chair of the ANZICS Intensive Care Research Coordinators Interest Group. Research interests include oxygen therapy, cardiac surgery associated acute kidney injury and enhanced recovery after thoracic surgery.

Photo of Sandra PeakeAssociate Professor Sandra L Peake BMBS BSc(Hons) FCICM PhD
Adjunct Associate Professor
Email

Dr Peake is a Senior Intensive Care Clinician in the Department of Intensive Care Medicine at The Queen Elizabeth Hospital, Adelaide and an Associate Professor in the School of Medicine at the University of Adelaide. She is Chair of the Intensive Care Foundation Scientific Committee, Chair of the Research Committee for the Acute Care Medicine Discipline at the University of Adelaide and a member of the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS-CTG) Executive Committee. She has been an examiner for the College of Intensive Care Medicine for the past 8 years. In 2000, she completed her PhD in Medicine at the University of Adelaide in the field of sepsis. Her thesis examined the role of combination anti-cytokine immunotherapy in an animal model of septic shock. Her main research interest now is large-scale, randomised clinical trials in critical care. She is currently Chair of the Management Committee for the NHMRC-funded, CTG-endorsed Australasian Resuscitation In Sepsis Evaluation (ARISE) multi-centre trial of early resuscitation in sepsis. She is also member of the Management Committee for the NHMRC-funded, CTG-endorsed multi-centre clinical trial of Early Parenteral Nutrition.

Photo of Ville PettilaAssociate Professor Ville Pettilä
Adjunct Associate Professor

Dr Pettilä is an Adjunct Associate Professor with the ANZIC-RC. He was the ANZIC-RC's Senior Research Fellow in 2009. Dr Pettilä was a Chief Investigator for the INFINITE Study, and is currently involved with a number of the ANZIC-RC's studies including TRANSFUSE and EPO-TBI, and as the Principal Investigator in Finland of the ARISE-RCT Study. In Finland, Dr Pettilä is the Head of Intensive Care Units at Helsinki University Hospital and Associate Professor in Intensive Care at Helsinki University. He has published over 140 papers in peer-reviewed journals including original manuscripts in the New England Journal of Medicine, Journal of the American Medical Association, British Journal of Haematology, Stroke, Intensive Care Medicine, and Critical Care Medicine. He was a member of several European multi-centre randomised trials in critical care including as Principal Investigator for Nordic countries in the Tissue Factor Pathway Inhibitor in Severe Sepsis trial. Dr Pettilä has also contributed to the Finnish Clinical Guidelines in severe sepsis in adults and acute kidney injury. He has supervised 8 dissertations at Helsinki University with topics including "APRV", "Acute renal failure in critically ill patients", "Severe sepsis in Finnish ICUs", "Hemodynamics and outcome in septic shock", and "Biomarkers in acute respiratory failure".

Photo of Dave PilcherProfessor David Pilcher MBBS MRCP FCICM FRACP
Adjunct Clinical Professor

Prof Pilcher has worked as an Intensive Care Specialist at The Alfred Hospital in Melbourne since 2006. He trained in respiratory and general medicine in the United Kingdom before coming to Australia to complete his Intensive Care fellowship in 2002. Prof Pilcher is Director of the ANZICS Adult Patient Database and Chair of the Australian and New Zealand Intensive Care Society Centre for Outcome and Resource Evaluation (ANZICS-CORE). He holds an Intensive Care Practitioner fellowship with Monash University. His research interests include organ donation, lung transplantation and the epidemiology of intensive care unit outcomes.

Publications in PubMed

Photo of Jeff PresneillAssociate Professor Jeff Presneill MBBS PhD MBiostat PGDipEcho FRACP FCICM
Adjunct Associate Professor

Dr Presneill is a Senior Staff Specialist, Department of Intensive Care Medicine, Royal Brisbane and Women's Hospital; an Associate Professor at the University of Queensland; and Adjunct Associate Professor at Monash University. Dr Presneill trained in respiratory medicine and intensive care then completed a doctoral thesis on aspects of the human immune response in severe sepsis and septic shock. Dr Presneill also undertook training in biostatistics and is an enthusiastic supporter of the Biostatistics Collaboration of Australia. He is involved in several large clinical studies through the Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), and is the current Queensland representative to the ANZICS Clinical Trials Group and the ANZICS Safety and Quality Committee.

Photo of Michael ReadeProfessor Michael Reade MBBS BSc MPH DPhil DMCC DIMCRCSEd PGCertAME AFRACMA FANZCA FCICM
Adjunct Professor

Professor Reade became the inaugural Australian Defence Force (ADF) Professor and Chair of Military Medicine and Surgery at the University of Queensland in 2011. An anaesthetist and intensivist, he also holds a clinical appointment at the Royal Brisbane and Women's Hospital and military appointments at both the ADF's Joint Health Command and the 2nd General Health Battalion of the Australian Army. He has >100 publications across the breadth of intensive care research, from applied molecular biology to statistical methodology and clinical trials. He is one of few intensivists with postgraduate qualifications in both basic science (doctorate University of Oxford) and statistics / epidemiology (MPH University of Pittsburgh). He has established collaborations with military medical research groups in the UK and USA looking at trauma systems design and novel therapies for blast injury and exsanguinating haemorrhage. In 2015 he completed a 15-hospital randomized controlled trial of dexmedetomidine as a treatment for critical illness agitated delirium. He is a chief investigator on NHMRC project grants totaling approx. $12M. He has deployed to Bosnia and Kosovo (on attachment to the British Airborne Brigade) and to East Timor and the Solomon Islands. In 2009 he was the clinical director of the NATO hospital, Tarin Kot, Afghanistan; in 2013 he was the Officer Commanding the Australian Specialist Health Group at the US Navy hospital in Kandahar, Afghanistan; and in 2015 he was the first Director of Clinical Services of an ADF hospital deployed on war-like operations. With the rank of Colonel, he is the Director of Clinical Services of the Australian Regular Army's only deployable hospital.

Photo of Elissa RobinsMs Elissa Robins APD AN
Adjunct Research Fellow

Ms Elissa Robins is an Accredited Practising Dietitian (APD) and Accredited Nutritionist (AN), with a current appointment as a Senior Dietitian in the Intensive Care Unit at the Prince Charles Hospital, Chermside, Brisbane. She is also an Adjunct Research Fellow with Monash University. Elissa completed her undergraduate studies (Bachelor of Health Science - Nutrition and Dietetics) at the University of Newcastle, NSW. She has been working as a clinical dietitian since 2004 and began her first foray into research in 2010 where she was successful in an equipment grant for an Indirect Calorimeter used for researching metabolic requirements in critically ill patients. She has participated in a number of research projects including the International Nutrition in Critically Ill Observational Study (2011 and 2013) and a multidisciplinary study of Micronutrient Disposition in an Ex-vivo ExtraCorporeal Membrane Oxygenation (ECMO) Circuit Model. Most recently she completed coordination of the first international multi-centre observational study across Australia New Zealand looking at Nutrition Therapy in Adult ECMO Patients which is pending publication. Elissa's areas of interest include nutritional requirements in critical illness, and more specifically the effect of nutrition delivery on lean body mass and long-term functional outcomes in this group. She is presently involved in a number of studies including the international multi-site MICROBIOME study looking at the gut flora and bacterial makeup of enterally fed ICU patients, and the PROTEIN pilot study looking at protein loading and muscle mass in lung transplant recipients.

Photo of Matthieu SchmidtDr Matthieu Schmidt MD AdvMSc(RespPhys)
Adjunct Senior Research Fellow

Dr Schmidt is an intensive care specialist in the Service de Réanimation Médicale, Institute of Cardiometabolism and Nutrition (iCAN), Groupe Hospitalier Pitié-Salpêtrière in Paris, France. His qualifications include an Advanced Master's degree in Respiratory Physiology (2009), a Diploma of Cardiac Ultrasonography (2010) and a Diploma in Artificial Ventilation (2008). For three years Dr Schmidt worked as an intensive care registrar in the medical intensive care units in La Pitié Salpêtrière hospital in Paris led by Pr Jean Chastre, Pr Alain Combes and Pr Thomas Similowski. He is a member of the French Speaking Society of Intensive Care (SRLF) and the European Society of Intensive Care Medicine (ESICM). Dr Schmidt's research interests include patient-ventilator interaction and extracorporeal membrane oxygenation, and he has >30 papers published in international refereed journals and 4 book chapters on these topics. Dr Schmidt was a Visiting Researcher at the ANZIC-RC from 2013 to 2014.

Photo of Ian SeppeltDr Ian Seppelt MBBS BMedSc FANZCA FCICM
Adjunct Senior Research Fellow

Dr Seppelt is a Senior Staff Specialist in the Department of Intensive Care Medicine, Nepean Hospital and Sydney Medical School, University of Sydney; Honorary Senior Research Fellow, The George Institute for International Health, Sydney; and Advanced Scholar and Clinical Senior Lecturer, Australian School of Advanced Medicine, Macquarie University. He is a Board Member and Secretary of the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS-CTG). He is a Management Committee member of the ANZIC-RC's INFINITE and SPICE studies, the Bacteraemic Load in Septic Shock (BLISS) study through the NHMRC CCRE in Critical Infection, and the ANZICS-CTG Point Prevalence Program. He is the ANZ lead for the international Selective Decontamination of the Digest Tract (SuDDICU) research program. Dr Seppelt's research interests include clinical research ethics, the clinical management of severe sepsis, neurotrauma, intensive care sedation and echocardiography in intensive care. He is a part owner of a very nice vineyard and is professional horse transport technician for his children.

Dr Markus Skrifvars

Dr Markus Skrifvars MD PhD FCICM EDIC
Adjunct Senior Research Fellow
Email

Markus Skrifvars is a Specialist in Intensive Care at the 18 bed ICU at Helsinki University Hospital. From 2016-2017 Dr Skirfvars completed a one year senior research fellowship at the ANZIC Research Centre in the School of Public Health and Preventive Medicine at Monash University. After completing his anaesthesia training in 2008, Markus Skrifvars completed an ICU fellowship, training at Liverpool Hospital in NSW, Australia in 2008-2011. After that he trained in Neuro Anaesthesia and Neuro Intensive Care as well as General Intensive Care at Helsinki University Hospital. His research has focused on ICU care of patients with cardiac arrest, as well as traumatic brain injury. He has 65 original research papers published to date. dr Skrifvars supervises several PhDs in both clinical, epidemiological and in experimental animal work. He was the national principal investigator in Finland for the ANZICS-CTG EPO-TBI trial (Lancet 2015). He is a member of the steering group for the TTH48 trial, a trial comparing 24 and 48 hours of therapeutic hypothermia treatment following cardiac arrest, as well the senior investigator for the COMACARE pilot trial focusing on oxygen, carbon dioxide and blood pressure targets in cardiac arrest patients. While at the ANZIC Research Centre he focused on the post hoc studies of the EPO-TBI trial, as well as several other projects.

Publications in PubMed

Photo of Mick StephensonMr Mick Stephenson ASM
Adjunct Research Fellow

Mr Mick Stephenson is Regional Manager and MICA Paramedic with Ambulance Victoria (AV) and a Sessional Lecturer at Monash University to MICA paramedic and AAV students. He is also a current Board Member (Director) and Committee Chair of the Emergency Services and State Superannuation Fund. Since 1996, he has worked for Ambulance Victoria with responsibilities including management of all aspects of ambulance in Gippsland , AV liaison role for major clinical trials of international significance; delivery of MICA road ambulance response for the Melbourne Metropolitan region; management of industrial relations issues for the MICA group and AV generally; serving on key AV committees such as Medical Advisory Committee, AV Board of Studies and the Credentialing Committee; provision of reports on MICA status and activity for the CEO, Committee of Management and Government; and to develop relationships and mentoring processes for rural MICA Team Managers with the metropolitan MICA Team Managers. Mr Stephenson has qualifications in emergency medicine and intensive care nursing. Mr Stephenson is a Management Committee Member on the ANZIC-RC's POLAR-RCT (Prophylactic Hypothermia Trial to Lessen Traumatic Brain Injury - Randomised Controlled Trial). In 2015, Mick was the recipient of an Ambulance Service Medal, in the Australia Day honours, for his distinguished service to Ambulance Victoria.

Photo of Andrew UdyAssociate Professor Andrew Udy BHB MB ChB PGCert(AME) PhD FCICM
Adjunct Associate Professor and Co-Deputy Director, ANZIC-RC
Mobile: +61 (0) 438 755 568
Email

Dr Andrew Udy is a full-time intensive care clinician and researcher at The Alfred ICU, Melbourne. He completed his undergraduate medical education at the University of Auckland, followed by ICU training in New Zealand, the United Kingdom and Australia. After award of Fellowship, Andrew worked as a consultant for many years in Queensland, while also completing a PhD in antibiotic pharmacokinetics. His major academic interests include optimised drug prescribing in the critically ill, haemodynamic management in severe sepsis, acute kidney injury and renal replacement therapy, management of subarachnoid haemorrhage, and critical care nutrition. Andrew is involved in critical care research internationally as the Victorian representative on the ANZICS Clinical Trials Group (CTG) Committee. He is also a keen educator; instructing on BASIC, ALS, ECMO and EMST courses, and is Deputy Chair of the Victorian Regional Committee (VRC), College of Intensive Care Medicine. Andrew is Co-Deputy Director of the Australian and New Zealand Intensive Care Research Centre, Monash University.

Publications in PubMed

Photo of Shirley VallanceMs Shirley Vallance MClinResMeth
Adjunct Research Fellow

Ms Shirley Vallance is Clinical Research Manager, Intensive Care, The Alfred Hospital. As an Investigator and/or Management Committee Member on several current ANZIC-RC studies including the EPO-TBI, PHARLAP and TRANSFUSE studies, Ms Vallance has had a long and productive collaboration with the ANZIC-RC. Since 2001, she has been involved in clinical research in intensive care at The Alfred Hospital, and prior to that was the Research Officer on the Consultative Committee on Road Traffic Fatalities, Victorian Institute Forensic Medicine. Ms Vallance also has training and experience in intensive care nursing, and a Masters degree in Clinical Research Methods. Ms Vallance is an author on 14 publications, mostly multi-centre clinical intensive care research, including publications in prestigious journals such as the New England Journal of Medicine. She was an investigator on 12 additional publications. Ms Vallance was an invited speaker at conferences including the International Neurotrauma Symposium in Rotterdam, The Netherlands. She is a reviewer of endorsement applications for the Australian and New Zealand Intensive Care Clinical Trials Group (ANZICS-CTG). Ms Vallance is a member of the Australian and New Zealand Intensive Care Society (ANZICS), the Australian and New Zealand Forensic Science Society and the Women in Neurotrauma Research Association.

Photo of Tricia WilliamsMs Patricia Williams RGN BNP (Int Care)
Adjunct Research Fellow

Ms Tricia Williams is a Donation Specialist - Nursing Coordinator at DonateLife South Australila. Previously she was the Research Project Nurse and Blood Gas Laboratory Manager, Department of Intensive Care Medicine at The Queen Elizabeth Hospital (TQEH), South Australia, and Affiliate Lecturer in the Discipline of Acute Care, School of Medicine, Faculty of Health Science at the University of Adelaide. Ms Williams was an Investigator and/or Management Committee Member on several ANZIC-RC studies including the ARISE randomised controlled trial and the ARISE health economic evaluation, STATINS, INFINITE and Fresh Blood studies. Ms Williams's qualifications include a Bachelor of Nursing Practice and several advanced courses in critical care nursing, and she is also a Registered Nurse. Since 1997, she has been involved in clinical research in intensive care at TQEH, initially as a Clinical Research Nurse, and since 2006 as the Research Project Nurse and Blood Gas Laboratory Manager. During that time, Ms Williams has been an Investigator on 38 research studies. Ms Williams has been an author/investigator on a number of publications, mostly multi-centre clinical intensive care research, including publications in Anaesthesia and Intensive Care. She was an invited presenter at the Australian and New Zealand Intensive Care Clinical Trials Group (ANZICS-CTG) Annual Scientific Meeting in 2010 and 2011. Ms Williams is an Executive Committee Member of the Intensive Care Research Coordinators Interest Group (IRCIG), and is also a member of the ANZICS-CTG and the Royal Australian Nursing Federation.

Photo of Judy WillsMs Judy Wills DCR DMU ASAR
Adjunct Research Fellow
Phone: + 61 3 9076 2437
Mobile: 0407 781 939

Ms Wills joined the ultrasound team at the Alfred Hospital in Melbourne in 2005. Her role as Chief Sonographer has been to supervise and develop clinical guidelines, increase the involvement of the ultrasound department with research projects, and to introduce a training programme for sonographers, radiology registrars, and medical students. Over the past eight years Judy has been Chief UltraSonographer (CUS) for critical care trials including PROTECT, RELEVENT, and EPO-TBI. In addition to the critical care trials, the sonographers have been involved in numerous studies, including the use and positioning of various IVC filters, renal denervation and other treatments for hypertension, medical treatment of haematological disorders, ultrasound assessment of bowel changes associated with Crohn's disease, and the assessment of fibrosis and fatty liver disease in patients with NASH and NAFLD. Ms Wills has been an invited speaker at numerous National Australian Sonographer Association Conferences, and was involved in writing the curriculum for the Monash University post-graduate degree in Medical Ultrasound.